ÌÒÖ­Ó°Ôº

Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Tables)

v3.23.1
Stockholders' Equity (Tables)
9 Months Ended
Jan. 31, 2023
Stockholders' Equity Note [Abstract] Ìý
Schedule of Restricted Stock Unit Activity
A summary of the Company’s RSU activity, granted under the 2012 and 2018 Equity Incentive Plans, during the nine months ended JanuaryÌý31, 2023 is presented below:
Restricted Stock Units Number of Shares Weighted Average Grant Date Fair Value
Unvested balance outstanding, April 30, 2022 929,928Ìý $ 6.12Ìý
Granted 15,000Ìý 0.35Ìý
Forfeits (185,059) 7.65Ìý
Vested (236,813) 0.70Ìý
Expired —Ìý —Ìý
Unvested balance outstanding, January 31, 2023 523,056Ìý $ 7.87Ìý
___________________
Summary of Warrant Activity A summary of the Company’s warrant activity during the nine months ended JanuaryÌý31, 2023 is presented below:
Warrants Number of
Shares
Weighted
Average
Exercise
Price
Weighted
Average
Remaining
Contractual
Term
Aggregate
Intrinsic
Value
Balance Outstanding, April 30, 2022 649,174Ìý $ 4.70Ìý 1.96 $ —Ìý
Granted —Ìý $ —Ìý —Ìý —Ìý
Exercised —Ìý $ —Ìý —Ìý —Ìý
Surrendered —Ìý $ —Ìý —Ìý —Ìý
Expired (224,174) $ 6.87Ìý —Ìý —Ìý
Balance Outstanding, January 31, 2023 425,000Ìý $ 3.56Ìý 3.02 $ —Ìý
Unvested (16,667)
Exercisable, January 31, 2023 408,333Ìý $ 3.42Ìý 3.00 $ —Ìý
Share-based Payment Arrangement, Option, Exercise Price Range
OUTSTANDING WARRANTS EXERCISABLE WARRANTS
Exercise
Price
Weighted
Average
Exercise
Price
Outstanding
Number of
Warrants
Weighted
Average
Exercise
Price
Weighted
Average
Remaining Life
In Years
Exercisable
Number of
Warrants
$ 1.00Ìý 1.00Ìý 200,000Ìý $ 1.00Ìý 4.23 200,000Ìý
$ 4.89Ìý $ 4.89Ìý 50,000Ìý $ 4.89Ìý 1.19 50,000Ìý
$ 5.85Ìý $ 5.85Ìý 50,000Ìý $ 5.85Ìý 3.58 50,000Ìý
$ 6.00Ìý $ 6.00Ìý 100,000Ìý $ 6.00Ìý 1.09 100,000Ìý
$ 6.99Ìý $ 6.99Ìý 25,000Ìý $ 6.99Ìý 3.47 8,333Ìý
Ìý 425,000Ìý Ìý Ìý 408,333Ìý
OUTSTANDING OPTIONS EXERCISABLE OPTIONS
Exercise
Price
Weighted
Average
Exercise
Price
Outstanding
Number of
Options
Weighted
Average
Exercise
Price
Weighted
Average
Remaining Life
In Years
Exercisable
Number of
Options
$3.24 to $4.38
$ 4.00Ìý 31,665Ìý $ 4.00Ìý 1.50 31,665Ìý
$4.50 to $5.20
$ 4.97Ìý 119,876Ìý $ 4.97Ìý 1.03 119,876Ìý
$7.17 to $7.55
$ 7.45Ìý 462,917Ìý $ 7.45Ìý 0.60 462,917Ìý
614,458Ìý 614,458Ìý
Summary of Stock Option Activity A summary of the Company’s stock option activity for employees and directors during the nine months ended JanuaryÌý31, 2023, is presented below:
Options Number of
Shares
Weighted
Average
Exercise
Price
Weighted
Average
Remaining
Contractual
Term
Aggregate
Intrinsic
Value
Balance Outstanding, AprilÌý30, 2022
860,182Ìý $ 7.03Ìý 1.25 $ —Ìý
Granted —Ìý —Ìý —Ìý —Ìý
Exercised —Ìý —Ìý —Ìý —Ìý
Forfeited (36,634) 8.89Ìý —Ìý —Ìý
Expired (209,090) 7.42Ìý —Ìý —Ìý
Balance Outstanding, JanuaryÌý31, 2023
614,458Ìý $ 6.79Ìý 0.73 $ —Ìý
Exercisable, JanuaryÌý31, 2023
614,458Ìý $ 6.79Ìý 0.73 $ —Ìý
Schedule of Share-Based Compensation
A summary of the Company’s stock-based compensation expense, which is included in "general and administrative" expense in the consolidated statement of operations is presented below:


Three Months Ended January 31, Nine Months Ended January 31,
2023 2022 2023 2022
RSUs $ 394,510Ìý $ 397,241Ìý $ 893,769Ìý $ 1,532,147Ìý
Restricted Stock —Ìý 286,231Ìý —Ìý 307,283Ìý
Stock options —Ìý 17,225Ìý 5,407Ìý 126,137Ìý
Total stock-based compensation expense $ 394,510Ìý $ 700,697Ìý $ 899,176Ìý $ 1,965,567Ìý